4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-355735
Chief Medical Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tripuraneni Radhika · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 1 in the form | +40,000 | $13.21 | $528,400 | 40,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −40,000 | 0 | D |
Loading xslF345X06/ownership.xml…